|
Report ID
|
163664 |
|
Drug Identification Number
|
02294346 |
|
Brand name
|
APIDRA |
|
Common or Proper name
|
Apidra Solostar |
|
Company Name
|
SANOFI-AVENTIS CANADA INC |
|
Market Status
|
MARKETED |
|
Active Ingredient(s)
|
INSULIN GLULISINE |
|
Strength(s)
|
100UNIT |
|
Dosage form(s)
|
SOLUTION |
|
Route of administration
|
SUBCUTANEOUS
SUBCUTANEOUS |
|
Packaging size
|
5 |
|
ATC code
|
A10AB |
|
ATC description
|
INSULINS AND ANALOGUES |
|
Reason for shortage
|
Delay in shipping of the drug. |
|
Anticipated start date
|
2022-07-04 |
|
Actual start date
|
2022-07-07 |
|
Estimated end date
|
2022-09-23 |
|
Actual end date
|
2022-09-23 |
|
Shortage status
|
Resolved |
|
Updated date
|
2022-09-26 |
|
Company comments
|
The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
|
Health Canada comments
|
|
|
Tier 3 Status
|
No |
| Company contact information |
email: [email protected]
Telephone: 1-800-265-7927 |
